Related Experiment Video
Updated: Feb 15, 2026

10:56
A User-friendly and Powerful R Analysis of Large-scale Datasets
Published on: November 4, 2025
403
A User-Friendly App for Blood Coagulation Disorders
1Appamedix, Innovations-Centrum CHIC, Berlin, Germany. jv@appamedix.com.
Methods in Molecular Biology (Clifton, N.J.)
|January 31, 2018
Summary
Maternal environment impacts offspring health, increasing risks for diseases like type 2 diabetes. This study introduces a test strip and app for patients to self-manage blood coagulation activity and monitor treatment effects.
Area of Science:
- Biomedical science
- Health technology
- Patient self-management
Background:
- Suboptimal maternal environment linked to offspring's age-associated diseases (type 2 diabetes, obesity, cardiovascular disease).
- Altered blood clotting time is a factor in these diseases and requires monitoring in specific patient groups.
- Coagulant medication management is crucial for patients with cardiovascular disorders and post-surgery.
Purpose of the Study:
- To describe a method for patient self-management of blood coagulation activity.
- To introduce a test strip device and accompanying mobile application (Coagu app) for this purpose.
- To highlight the app's utility in treatment monitoring and adherence.
Main Methods:
- Utilizes a test strip device for measuring blood coagulation activity.
- Employs the Coagu app for data logging and analysis.
- The app serves as a tool for treatment reminders and long-term effect monitoring.
Main Results:
- Enables patients to actively participate in managing their blood coagulation.
- Provides a convenient method for tracking treatment efficacy over time.
- Facilitates timely adherence to medication schedules.
Conclusions:
- Patient self-management of blood coagulation is feasible with the described technology.
- The Coagu app supports treatment adherence and monitoring, potentially improving outcomes for individuals at risk of or with age-associated diseases.
- This approach empowers patients in managing conditions affected by blood clotting time.
Related Concept Videos
Coagulation
1.5K
Colloidal solids are solid particles suspended in solution. They are usually negatively charged, attracting a compact primary layer of positively charged ions, which attract more counterions to form an electrical double layer. Electrostatic repulsion between the charged double layers prevents the particles from colliding, stabilizing the colloids. These solids are often undesirable because they can contain toxins that are difficult to remove. Coagulation is a technique that helps aggregate and...
1.5K
Coagulation
10.7K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
10.7K
Intrinsically Disordered Proteins
19.6K
Intrinsically disordered proteins are a group of proteins that do not fold into specific three-dimensional structures. Their structural flexibility allows them to complement ordered proteins to perform functions that are inaccessible to rigid structures. They are more common in eukaryotes than prokaryotes and may either be exclusively intrinsically disordered or hybrid proteins, consisting of a mix of ordered and disordered regions. The absence of a rigid structure in these proteins can be...
19.6K
Bone Disorders
5.5K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
5.5K
Disorders of Erythrocytes
2.3K
Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
2.3K
Disorders of Leukocytes
2.0K
Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
2.0K

